How Genentech, Novartis Stifled A Promising Drug – WSJ Tue, 05 Apr 2005 A front page story in The Wall Street Journal should be distributed to every Congress person who will be considering Bioshield II providing yet additional financial incentives and give-a-ways to pharmaceutical companies. The story perfectly illustrates this…
Science Reporters Don’t Notice Conflicts of Interest Tue, 3 Dec 2002 An article by Neil Munro, in The Washington Monthly (below) exposes a journalistic failure by major science reporters. By examining how The New York Times, The Washington Post, and The Chicago Tribune have reported stem cell and cloning research,…
Eli Lilly Wants Insurers to Pay $1 billion in Zyprexa claims – AP Tue, 13 Sep 2005 The Associated Press reported that Eli Lilly is trying to pass the buck to insurers– In addition to the $700 million Lilly agreed to pay to settle a lawsuit over the company having…
NGO Probe to Look at Foster Kids in AIDS Drug Trials – NYC Sat, 23 Apr After a year of stonewalling, the New York City Administration for Children’s Services has announced that it would seek “an independent review” of the AIDS drug trials that were conducted on children in the…
When Doctors Go to Class, Industry Often Foots the Bill – WSJ Fri, 6 Dec 2002 A front page article in The Wall Street Journal by Scott Hensley sheds further light on the corruption of medical ethics by focusing on a drug marketing ploy that is promoted as “continuing medical…
Doctor Chides Medical Societies to Take Action – GSK Fined $150 Million in Medicare Fraud Wed, 21 Sep 2005 The latest in a series of fraud settlements, GlaxoSmithKline has agreed to pay $150 million to settle fraud allegations over inflating price of Zorfran and Kytril (nausea drugs) when billing Medicare…
Supreme Court Decision On Right to Sue For Pesticide Harm Wed, 27 Apr 2005 Good news! The Supreme Court ruled unanimously that people who have been damaged by pesticides have the right to sue manufacturers of these poisons. Many of you will recall that the EPA wanted to conduct an…
Homeland Security bill – Pharma Immunity – WP Fri, 15 Nov 2002 The Homeland Security bill that passed the House includes sweeping last minute provisions attached to it that have nothing to do with the war on terrorism. The provisions put the interest of pharmaceutical industry giants above the health…
At FDA, Changes In Name Only–Agency Puts Business interests Above Safety Fri, 30 Sep 2005 The sudden resignation of FDA Commissioner, Lester Crawford, after just two months in office, has prompted a bipartisan Senate investigation and requests both by the Senate committee HELP and by congressman Maurice Hinchey (NY) and…
October 29, 2001 FYI Widely disparate perspectives are presented in an article in the Maryland Daily Record re: The Court of Appeals of Maryland decision (Gimes v Kennedy Krieger Institute, Aug 16, 2001). That 6-to-1 landmark decision severely criticized the practice of exposing healthy children to risks of harm in…
Bayh-Dole Act: The Law of Unintended Consequences – Fortune Sun, 25 Sep 2005 The author of this Infomail is Dianne N. Irving, M.A., Ph.D. Revisiting the Bayh-Dole Act (1980): Spawned Big Biotech, Now Has Opposite Debilitating Effects Today’s specter of harmful and inordinately priced drugs pressed on legislators and the…
Medicare Rx Drug Bill Shaped by Drug Industry Blocks Elderly Bargaining Power – NYT Fri, 5 Sep 2003 A drug industry lobbyist is quoted in The New York Times stating: “Having both houses of Congress Republican-controlled was great. Like in Monopoly, when you get to add hotels.” The Medicare prescription…
